Skip to main content
Equibles

FIRST TRUST ADVISORS LP

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1125816 Wheaton, IL
Back to LGND Full portfolio

Position in LGND

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$28,730,368
+$12,678,309 QoQ
Shares Held
90,893
+13.0% QoQ
Ownership
0.456%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#51
of 415 holders
Holding Since
Sep 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FIRST TRUST ADVISORS LP holds $2,844,450,753 across 98 Biotechnology names. LGND ranks #21 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 547,132 $341,158,687
2 INCY
Incyte Corp
 1,587,996 $180,015,226
3 CORT
Corcept Therapeutics Inc
 1,829,545 $159,078,937
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 289,179 $143,643,884
5 EXEL
Exelixis, Inc.
 2,543,353 $138,383,836
6 ALNY
Alnylam Pharmaceuticals, Inc.
 421,534 $126,894,380
7 KRYS
Krystal Biotech, Inc.
 324,900 $120,755,583
8 AXSM
Axsome Therapeutics, Inc.
 482,061 $117,994,070

All Filings in LGND

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $28,730,368 90,893
2026-03-31 $16,052,059 80,401
2025-12-31 $13,087,425 69,220
2025-09-30 $9,156,012 51,688
2025-06-30 $5,552,131 48,840
2025-03-31 $3,392,867 32,270
2024-12-31 $3,570,880 33,326
2024-09-30 $3,536,880 35,337
2024-06-30 $2,682,417 31,835
2024-03-31 $1,514,997 20,725
2023-12-31 $1,515,318 21,217
2023-09-30 $1,075,863 17,955
2023-03-31 $1,247,209 16,955
2022-12-31 $285,770 4,278
2022-09-30 $947,123 10,999
2022-06-30 $1,234,090 13,832
2022-03-31 $894,183 7,949
2021-12-31 $659,543 4,270
2021-09-30 $1,748,325 12,549
2021-06-30 $4,214,609 32,126
2020-12-31 $605,053 6,084
2020-09-30 $1,847,873 19,386